Background The role of molecular markers in salivary gland carcinoma (SGC) is not well
understood. We evaluated molecular marker expression and their prognostic value …

Background Salivary duct carcinoma (SDC) is a highly aggressive disease which often
metastasizes to distant sites, and there is no established standard therapy for this systemic …

Objectives Salivary duct carcinoma (SDC) is a rare and aggressive subtype of salivary gland
cancer. Androgen receptor (AR)(96%) and HER2 (29–46%) expression, and a high …

Salivary duct carcinoma (SDC) is one of the most aggressive salivary gland tumors, and
prognosis remains poor for most patients. The aim of this study was to investigate the …

Background Although programmed cell death-ligand 1 (PD-L1) has been recognized as a
potential marker in several cancers, the relationship between PD-L1 expression and survival …

The molecular characteristics of therapeutically-relevant targets and their clinicopathological
implications in salivary duct carcinomas (SDCs) are poorly understood. We investigated the …

Molecular targets and predictive biomarkers for prognosis in salivary duct carcinoma (SDC)
have not been fully identified. We conducted comprehensive molecular profiling to discover …

Objectives There is currently no established algorithm for the molecular profiling of therapy‐
relevant defects in salivary gland carcinomas (SGC). HER 2 overexpression in a subfraction …

Salivary gland carcinomas (SGCs) are rare tumors encompassing a wide spectrum of
histologic/biologic entities. Standard non-surgical treatments are ineffective in case of …

Simple Summary We describe the currently known histopathological aspects of the
prognostic factors for salivary gland cancers and discuss the genetics or molecules used as …